Rare diseases
Investigational molecules
Locations
Back to Germany1 191 clinical trials in Munich, Germany across 8 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Study on the Effects of Cyclosporine A in Patients with Takotsubo Syndrome
GermanyStudy Comparing OSE2101 and Docetaxel for Patients with Metastatic Non-Small Cell Lung Cancer After Immunotherapy Resistance
GermanyStudy of trabectedin alone versus trabectedin with tTF-NGR combination therapy in adults with metastatic or refractory soft tissue sarcoma who failed first-line treatment
GermanyStudy on the Safety and Effects of STX-241 for Patients with Advanced Non-Small Cell Lung Cancer Resistant to EGFR Inhibitors
GermanyLong-Term Safety and Efficacy Study of Givinostat for Patients with Duchenne Muscular Dystrophy Previously Treated with Givinostat
GermanyStudy of zongertinib tablets in patients with advanced solid tumors that have HER2 gene changes
GermanyStudy on the Safety and Effectiveness of Teclistamab and Talquetamab for Patients with Newly Diagnosed Multiple Myeloma Eligible for Transplant
GermanyStudy on Inhaled Colistimethate Sodium for Adults with Bronchiectasis and New Asymptomatic Pseudomonas Aeruginosa Infection
GermanyStudy on Adding Navtemadlin to Ruxolitinib for Patients with Myelofibrosis and Suboptimal Response to Ruxolitinib
GermanyStudy on Atezolizumab with FOLFOX for Stage III Colon Cancer with Deficient DNA Mismatch Repair
GermanyStudy of Temozolomide and Lomustine Followed by Radiotherapy versus Standard Treatment in Patients with Newly Diagnosed Grade 2 or 3 Glioma
GermanyStudy on the Safety and Effects of SPK-3006 for Adults with Late-Onset Pompe Disease
GermanyThe busiest research cities in the country
What the registry says about research in the country
In München, clinical trials in oncology and blood cancers focus on improving survival, controlling relapse, and refining treatment strategies for a wide range of cancers.
These studies are testing new combinations and comparative approaches to strengthen cancer control and better support patients with advanced or hard-to-treat disease.
Trials in cardiovascular medicine are examining ways to lower major events, improve post-procedure care, and optimize long-term protection in high-risk patients.
Much of this work aims to improve treatment effectiveness while reducing serious cardiovascular complications.
Respiratory research in this city is broad, with studies centered on chronic lung disease, inflammation, and treatment options for people with difficult-to-control symptoms.
These trials are mainly evaluating whether new therapies can improve breathing, symptom control, and long-term lung outcomes.
Neurological research spans emergency stroke care, chronic neurodegenerative disorders, and therapies aimed at preserving daily function and quality of life.
Research here is exploring better acute treatments, symptom relief, and disease-modifying approaches for progressive neurological conditions.
Several studies address immune-mediated diseases, including skin disorders and systemic inflammatory conditions, with the goal of improving symptom control and reducing flare burden.
These trials are assessing whether newer targeted treatments can provide better and more durable relief for inflammatory disease.
Research in metabolic disease focuses on diabetes control, obesity management, and reduction of long-term cardiometabolic risk.
The overall aim is to test therapies that may improve glucose control, support weight loss, and lower future complications.
Eye disease trials are looking at ways to protect vision and slow progression in conditions that can lead to irreversible damage.
These studies are designed to improve treatment options for patients facing progressive vision loss.
Clinical research in infectious disease includes both prevention and treatment, with attention to viral infection and serious respiratory illness.
These trials aim to strengthen prevention strategies and improve outcomes in infections that can place a heavy burden on patients and healthcare systems.
Studies in urology and kidney disease address both cancer and transplant-related care, along with advanced prostate cancer.
Research in this area is focused on improving treatment effectiveness, organ outcomes, and long-term patient safety.
Trials here cover musculoskeletal disease and persistent pain, seeking better ways to relieve symptoms that often limit mobility and daily activity.
The main goal is to evaluate therapies that may provide stronger and more lasting pain relief.
Several studies in München address rare diseases and childhood cancers, where new treatment approaches are especially important.
These trials are testing ways to improve outcomes for young patients with aggressive or recurrent disease.
Some studies bridge allergy, inflammation, and respiratory disease, reflecting the role of immune pathways in chronic symptoms.
These trials are evaluating targeted treatments that may better control inflammation and reduce flare-ups.
A portion of the trial portfolio does not fit neatly into one specialty, reflecting broad research across overlapping medical conditions and complex patient groups.
These studies often aim to improve overall treatment benefit, safety, and real-world applicability across different patient populations.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
